Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
5,434,244
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
1,704,277
-
Shares change
-
-436,267
-
Total reported value, excl. options
-
$1,109,338
-
Value change
-
-$364,998
-
Put/Call ratio
-
2.6%
-
Number of buys
-
2
-
Number of sells
-
-20
-
Price
-
$0.6508
Significant Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) as of Q3 2022
34 filings reported holding APRE - Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q3 2022.
Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,704,277 shares
of 5,434,244 outstanding shares and own 31% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (311,591 shares), VANGUARD GROUP INC (309,598 shares), RENAISSANCE TECHNOLOGIES LLC (282,541 shares), BlackRock Inc. (185,741 shares), GEODE CAPITAL MANAGEMENT, LLC (150,142 shares), MILLENNIUM MANAGEMENT LLC (121,333 shares), BNP PARIBAS ARBITRAGE, SNC (61,847 shares), STATE STREET CORP (40,832 shares), GROUP ONE TRADING, L.P. (31,003 shares), and NORTHERN TRUST CORP (28,710 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.